Dr. Johnson is primarily a lung transplant clinician with clinical research interests in lung transplant therapies. He participated in the first ever randomized controlled trial in lung transplant, the first and only randomized, placebo controlled trial ever shown to improve survival after lung transplant and was the first ever to report a case series of recurrence of pre-transplant disease in the allograft.
Dr. Johnson’s practice focuses on the pre and post-transplant care of lung transplant recipients. He has been actively and continuously managing these patients since 1991 and is the senior clinician in lung transplantation at UPMC. As such, he is one of the most experienced transplant clinicians in the world. Other clinical interests include interventional bronchoscopy and he is the director of bronchoscopy services at UPMC.
- BS, Ohio State University, 1981
- MD, Ohio State University, 1986
- Residency, University of Pittsburgh, 1989
- Fellowship, Critical Care, University of Pittsburgh, 1990
- Research Fellowship, Critical Care, Chicago Medical School, 1991
- Clinical Fellowship, Pulmonary Transplant, University of Pittsburgh, 1992
- Research Fellowship, Pulmonary, University of Pittsburgh, 1994
Education & Training
Corcoran, TE, Niven, R, Verret, W, Dilly, S, Johnson, BA. Lung deposition and pharmacokinetics of nebulized cyclosporine in lung transplant patients. J Aerosol Med Pulm Drug Deliv. 2014; Jun;27(3): 178-84.
Crespo, MM, Johnson, BA, McCurry, KR, Landreneau, RJ, Sciurba, FC. Use of endobronchial valves for native lung hyperinflation associated with respiratory failure in a single lung transplant recipient for Emphysema. Chest. 2007; Jan;131(1): 214-6.
Iacono, AT, Johnson, BA, Corcoran, TE, Grgurich, WF, Youssef, JG, Seiler, DA, Dauber, JH, Smaldone, GC, Zeevi, A, Yousem, SA, Fung, JJ, Burckart, GJ, McCurry, KR, Griffith, BP. A randomized trial of inhaled Cyclosporine in lung transplant recipients. N Engl J Med. 2006; Jan 12;354(2): 141-150.
Johnson, BA, Iacono, AT, Zeevi, A, McCurry, KR, Duncan, SR. Statin use is associated with improved function and survival of lung allografts. Am J Respir Crit Care Med. 2003; 167(9): 1271-8.
Burns, KE, Johnson, BA, Iacono, AT. Diagnostic properties of transbronchial biopsy in lung transplant recipients who require mechanical ventilation. J Heart Lung Transplant. 2003; Mar 22: 267-275.
Duncan, SR, Grgurich, WF, Iacono, AT, Burckart, GJ, Yousem, SA, Paradis, IL, Williams, PA, Johnson, BA, Griffith, BP. A randomized comparison of ganciclovir and acyclovir regimens for prevention of cytomegalovirus infections in lung allograft recipients. Am J Respir Crit. 1994; 150: 146-152.
Johnson, BA, Duncan, SR, Paradis, IL, Yousem, SA, Grgurich, WF, Dauber, JH, Griffith, BP. Recurrence of sarcoidosis in pulmonary allograft recipients. Am Rev Respir Dis. 1993; 148: 1373-1377.
